Clinical Report: Infection Risks Following Colonization by MDR Gram-Negative Bacteria

Overview

This umbrella review and meta-analysis assessed infection risk after colonization with multidrug-resistant gram-negative bacteria (MDR-GNB), focusing on ESBL-producing and carbapenem-resistant Enterobacterales. The pooled incidence of infection following colonization was approximately 22% for both ESBL-E and CRE, highlighting a substantial risk of subsequent infection.

Background

Multidrug-resistant gram-negative bacteria (MDR-GNB) such as ESBL-producing Enterobacterales (ESBL-E) and carbapenem-resistant Enterobacterales (CRE) pose a significant global health threat due to limited treatment options and high mortality. Colonization with these bacteria, often asymptomatic, is a recognized risk factor for developing infections. Despite various decolonization strategies, consistent clinical benefits remain elusive, underscoring the need for precise data on infection risk post-colonization to guide clinical management and trial design.

Data Highlights

Key Findings

• The pooled incidence of infection following colonization was 22% for both ESBL-E and CRE.
• Few high-quality data exist regarding mortality or transmission outcomes following colonization.
• Limited systematic reviews addressed MDR Pseudomonas aeruginosa or carbapenem-resistant Acinetobacter baumannii.
• Heterogeneity in study populations and methodologies limits generalizability of findings.
• Colonization is a significant risk factor for subsequent infection with MDR-GNB.

Clinical Implications

Clinicians should recognize that approximately one in five patients colonized with ESBL-E or CRE may develop an infection, informing patient counseling and risk stratification. These findings support the need for improved infection prevention strategies and provide benchmarks for designing clinical trials of novel decolonization interventions. Awareness of the limited data on other MDR-GNB highlights areas for future research.

Conclusion

Colonization with multidrug-resistant gram-negative bacteria, particularly ESBL-E and CRE, carries a substantial risk of subsequent infection. These insights are critical for guiding clinical management, infection control, and the development of new therapeutic strategies.

References

1. Infection Risks Linked to Colonization by Multidrug-Resistant Gram-Negative Bacteria: A Comprehensive Review and Meta-Analysis, 2024